发明公开
EP2061503A2 CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
审中-公开
细胞毒性T淋巴细胞诱导免疫表型用于癌症的预防，治疗和诊断
- 专利标题： CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER
- 专利标题（中）： 细胞毒性T淋巴细胞诱导免疫表型用于癌症的预防，治疗和诊断
-
申请号： EP07872281.6申请日： 2007-08-30
-
公开(公告)号： EP2061503A2公开(公告)日： 2009-05-27
- 发明人: PHILIP, Ramila , KELLER, Lorraine
- 申请人： Immunotope, Inc.
- 申请人地址： The Pennsylvania Biotechnology Center 380 Old Easton Road Doylestown, PA 18902 US
- 专利权人： Immunotope, Inc.
- 当前专利权人： Immunotope, Inc.
- 当前专利权人地址： The Pennsylvania Biotechnology Center 380 Old Easton Road Doylestown, PA 18902 US
- 代理机构： Bassett, Richard Simon
- 优先权： US841121P 20060830; US846872 20070829
- 国际公布： WO2008088583 20080724
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K38/08 ; C07H21/04 ; C07K5/00
摘要：
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as breast carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against breast or cancer.
信息查询
